Literature DB >> 25234602

Improved conduction and increased cell retention in healed MI using mesenchymal stem cells suspended in alginate hydrogel.

Nikhil C Panda1, Sean T Zuckerman, Olurotimi O Mesubi, David S Rosenbaum, Marc S Penn, J Kevin Donahue, Eben Alsberg, Kenneth R Laurita.   

Abstract

INTRODUCTION: Mesenchymal stem cells (MSCs) have been associated with reduced arrhythmias; however, the mechanism of this action is unknown. In addition, limited retention and survival of MSCs can significantly reduce efficacy. We hypothesized that MSCs can improve impulse conduction and that alginate hydrogel will enhance retention of MSCs in a model of healed myocardial infarction (MI). METHODS AND
RESULTS: Four weeks after temporary occlusion of the left anterior descending artery (LAD), pigs (n = 13) underwent a sternotomy to access the infarct and then were divided into two studies. In study 1, designed to investigate impulse conduction, animals were administered, by border zone injection, 9-15 million MSCs (n = 7) or phosphate-buffered saline (PBS) (control MI, n = 5). Electrogram width measured in the border zone 2 weeks after injections was significantly decreased with MSCs (-30 ± 8 ms, p < 0.008) but not in shams (4 ± 10 ms, p = NS). Optical mapping from border zone tissue demonstrated that conduction velocity was higher in regions with MSCs (0.49 ± 0.03 m/s) compared to regions without MSCs (0.39 ± 0.03 m/s, p < 0.03). In study 2, designed to investigate MSC retention, animals were administered an equal number of MSCs suspended in either alginate (2 or 1 % w/v) or PBS (n = 6/group) by border zone injection. Greater MSC retention and survival were observed with 2% alginate compared to PBS or 1% alginate. Confocal immunofluorescence demonstrated that MSCs survive and are associated with expression of connexin-43 (Cx43) for either PBS (control), 1%, or 2% alginate.
CONCLUSIONS: For the first time, we are able to directly associate MSCs with improved impulse conduction and increased retention and survival using an alginate scaffold in a clinically relevant model of healed MI.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25234602      PMCID: PMC5746424          DOI: 10.1007/s10840-014-9940-9

Source DB:  PubMed          Journal:  J Interv Card Electrophysiol        ISSN: 1383-875X            Impact factor:   1.900


  44 in total

1.  Injectable hydrogel properties influence infarct expansion and extent of postinfarction left ventricular remodeling in an ovine model.

Authors:  Jamie L Ifkovits; Elena Tous; Masahito Minakawa; Masato Morita; J Daniel Robb; Kevin J Koomalsingh; Joseph H Gorman; Robert C Gorman; Jason A Burdick
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-07       Impact factor: 11.205

2.  Intracoronary bone marrow cell transfer after myocardial infarction: eighteen months' follow-up data from the randomized, controlled BOOST (BOne marrOw transfer to enhance ST-elevation infarct regeneration) trial.

Authors:  Gerd P Meyer; Kai C Wollert; Joachim Lotz; Jan Steffens; Peter Lippolt; Stephanie Fichtner; Hartmut Hecker; Arnd Schaefer; Lubomir Arseniev; Bernd Hertenstein; Arnold Ganser; Helmut Drexler
Journal:  Circulation       Date:  2006-03-06       Impact factor: 29.690

3.  Bone marrow mesenchymal stem cells stimulate cardiac stem cell proliferation and differentiation.

Authors:  Konstantinos E Hatzistergos; Henry Quevedo; Behzad N Oskouei; Qinghua Hu; Gary S Feigenbaum; Irene S Margitich; Ramesh Mazhari; Andrew J Boyle; Juan P Zambrano; Jose E Rodriguez; Raul Dulce; Pradip M Pattany; David Valdes; Concepcion Revilla; Alan W Heldman; Ian McNiece; Joshua M Hare
Journal:  Circ Res       Date:  2010-07-29       Impact factor: 17.367

4.  Engraftment patterns of human adult mesenchymal stem cells expose electrotonic and paracrine proarrhythmic mechanisms in myocardial cell cultures.

Authors:  Saïd F A Askar; Arti A Ramkisoensing; Douwe E Atsma; Martin J Schalij; Antoine A F de Vries; Daniël A Pijnappels
Journal:  Circ Arrhythm Electrophysiol       Date:  2013-02-18

5.  Unique topographical distribution of M cells underlies reentrant mechanism of torsade de pointes in the long-QT syndrome.

Authors:  Fadi G Akar; Gan-Xin Yan; Charles Antzelevitch; David S Rosenbaum
Journal:  Circulation       Date:  2002-03-12       Impact factor: 29.690

6.  Optical mapping of late myocardial infarction in rats.

Authors:  William R Mills; Niladri Mal; Farhad Forudi; Zoran B Popovic; Marc S Penn; Kenneth R Laurita
Journal:  Am J Physiol Heart Circ Physiol       Date:  2005-10-07       Impact factor: 4.733

7.  Human adult bone marrow mesenchymal stem cells repair experimental conduction block in rat cardiomyocyte cultures.

Authors:  Saskia L M A Beeres; Douwe E Atsma; Arnoud van der Laarse; Daniël A Pijnappels; John van Tuyn; Willem E Fibbe; Antoine A F de Vries; Dirk L Ypey; Ernst E van der Wall; Martin J Schalij
Journal:  J Am Coll Cardiol       Date:  2005-10-21       Impact factor: 24.094

8.  Bone marrow cells are a rich source of growth factors and cytokines: implications for cell therapy trials after myocardial infarction.

Authors:  Mortimer Korf-Klingebiel; Tibor Kempf; Thomas Sauer; Eva Brinkmann; Philipp Fischer; Gerd P Meyer; Arnold Ganser; Helmut Drexler; Kai C Wollert
Journal:  Eur Heart J       Date:  2008-10-25       Impact factor: 29.983

9.  Safety and efficacy of an injectable extracellular matrix hydrogel for treating myocardial infarction.

Authors:  Sonya B Seif-Naraghi; Jennifer M Singelyn; Michael A Salvatore; Kent G Osborn; Jean J Wang; Unatti Sampat; Oi Ling Kwan; G Monet Strachan; Jonathan Wong; Pamela J Schup-Magoffin; Rebecca L Braden; Kendra Bartels; Jessica A DeQuach; Mark Preul; Adam M Kinsey; Anthony N DeMaria; Nabil Dib; Karen L Christman
Journal:  Sci Transl Med       Date:  2013-02-20       Impact factor: 17.956

10.  Bone marrow cells adopt the cardiomyogenic fate in vivo.

Authors:  Marcello Rota; Jan Kajstura; Toru Hosoda; Claudia Bearzi; Serena Vitale; Grazia Esposito; Grazia Iaffaldano; M Elena Padin-Iruegas; Arantxa Gonzalez; Roberto Rizzi; Narissa Small; John Muraski; Roberto Alvarez; Xiongwen Chen; Konrad Urbanek; Roberto Bolli; Steven R Houser; Annarosa Leri; Mark A Sussman; Piero Anversa
Journal:  Proc Natl Acad Sci U S A       Date:  2007-10-26       Impact factor: 11.205

View more
  18 in total

Review 1.  Concise review: tailoring bioengineered scaffolds for stem cell applications in tissue engineering and regenerative medicine.

Authors:  Steffen Cosson; Ellen A Otte; Hadi Hezaveh; Justin J Cooper-White
Journal:  Stem Cells Transl Med       Date:  2015-01-09       Impact factor: 6.940

2.  Repeated doses of cardiac mesenchymal cells are therapeutically superior to a single dose in mice with old myocardial infarction.

Authors:  Yiru Guo; Marcin Wysoczynski; Yibing Nong; Alex Tomlin; Xiaoping Zhu; Anna M Gumpert; Marjan Nasr; Senthikumar Muthusamy; Hong Li; Michael Book; Abdur Khan; Kyung U Hong; Qianhong Li; Roberto Bolli
Journal:  Basic Res Cardiol       Date:  2017-02-16       Impact factor: 17.165

3.  Mesenchymal stem cells suppress cardiac alternans by activation of PI3K mediated nitroso-redox pathway.

Authors:  Prasongchai Sattayaprasert; Drew M Nassal; Xiaoping Wan; Isabelle Deschenes; Kenneth R Laurita
Journal:  J Mol Cell Cardiol       Date:  2016-05-26       Impact factor: 5.000

4.  Hyaluronan and elastin-like protein (HELP) gels significantly improve microsphere retention in the myocardium.

Authors:  Riley A Suhar; Vanessa M Doulames; Yueming Liu; Meghan E Hefferon; Oscar Figueroa; Hana Buabbas; Sarah C Heilshorn
Journal:  Biomater Sci       Date:  2022-05-17       Impact factor: 7.590

5.  Design of Injectable Materials to Improve Stem Cell Transplantation.

Authors:  Laura M Marquardt; Sarah C Heilshorn
Journal:  Curr Stem Cell Rep       Date:  2016-07-01

6.  Engineered Biomaterials to Enhance Stem Cell-Based Cardiac Tissue Engineering and Therapy.

Authors:  Anwarul Hasan; Renae Waters; Boustany Roula; Rahbani Dana; Seif Yara; Toubia Alexandre; Arghya Paul
Journal:  Macromol Biosci       Date:  2016-03-08       Impact factor: 4.979

7.  Heart Regeneration with Embryonic Cardiac Progenitor Cells and Cardiac Tissue Engineering.

Authors:  Shuo Tian; Qihai Liu; Leonid Gnatovskiy; Peter X Ma; Zhong Wang
Journal:  J Stem Cell Transplant Biol       Date:  2015-04-20

8.  Repeated Administrations of Cardiac Progenitor Cells Are Markedly More Effective Than a Single Administration: A New Paradigm in Cell Therapy.

Authors:  Yukichi Tokita; Xian-Liang Tang; Qianhong Li; Marcin Wysoczynski; Kyung U Hong; Shunichi Nakamura; Wen-Jian Wu; Wei Xie; Ding Li; Greg Hunt; Qinghui Ou; Heather Stowers; Roberto Bolli
Journal:  Circ Res       Date:  2016-06-30       Impact factor: 17.367

Review 9.  Translational Applications of Hydrogels.

Authors:  Santiago Correa; Abigail K Grosskopf; Hector Lopez Hernandez; Doreen Chan; Anthony C Yu; Lyndsay M Stapleton; Eric A Appel
Journal:  Chem Rev       Date:  2021-05-03       Impact factor: 60.622

10.  Nerolidol attenuates isoproterenol-induced acute myocardial infarction in rats.

Authors:  Meire S S Gonçalves; Eric Aian P Silva; Danillo M Santos; Izabel R Santana; Diego S Souza; Andreza M Araujo; Luana Heimfarth; Carla M L Vasconcelos; Vinícius C O Santos; Márcio R V Santos; Rosana de S S Barreto; Lucindo J Quintans Júnior; André S Barreto
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2022-01-20       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.